Skip to search formSkip to main contentSkip to account menu

dl1520

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
OBJECTIVE To evaluate the antitumor efficacy of Ad-TD-RFP for human nasopharyngeal carcinoma cells (C666-1) in vitro and in vivo… 
2005
2005
New clinical trial data on the use of the ONYX-015 adenovirus as a chemosensitizing agent indicate that further study of this… 
2005
2005
Objective To evaluate the efficiency of cell killing and growth inhibition of oncolytic virus dl1520 on hepatic carcinoma cells… 
2003
2003
ONYX-015 (dl1520) is an E1B 55-kilodalton protein-deficient replicating adenovirus that is currently in clinical trials as an… 
2001
2001
It has been suggested the E1B 55 kDa mutant adenovirus dl1520 can selectively killp53-deficient human tumor cells. In this study… 
1999
1999
An E1B gene-attenuated adenovirus ( dl1520) has been proposed to have a selective cytolytic activity in cancer cells with a…